Skip to the page

Data / Form D filings / Exosome Diagnostics, Inc.

Exosome Diagnostics, Inc.: Form D filings

Exosome Diagnostics, Inc., a biotechnology company in Waltham, MA, filed 9 Form D notices with the SEC between 2010 and 2017. The latest, on July 6, 2017, reports $30.3 million sold of a $30.3 million offering to 43 investors.

Find out what Exosome Diagnostics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
266 2nd Avenue, Waltham, MA, 02451
Phone
(617) 588-0500
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1491340

The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 6, 2017New notice$30,290,634$30,290,634$043Jun 21, 2017sec.gov
Sep 15, 2015New noticeIndefinite$15,530,538Indefinite9Aug 31, 2015sec.gov
Jul 6, 2015New notice$2,200,000$1,483,973$716,02712Jun 19, 2015sec.gov
Mar 13, 2014New notice$39,999,985$27,092,442$12,907,54326Mar 3, 2014sec.gov
Aug 15, 2013Amendment$8,500,000$7,000,000$1,500,0002Aug 10, 2012sec.gov
Jun 11, 2013Amendment$8,000,000$6,500,000$1,500,0002Aug 10, 2012sec.gov
Feb 4, 2013Amendment$6,000,000$5,000,000$1,000,0002Aug 10, 2012sec.gov
Aug 23, 2012New notice$4,000,000$3,000,000$1,000,0002Aug 10, 2012sec.gov
May 12, 2010New notice$22,495,000$9,495,000$13,000,00010Apr 28, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Peter JohannDirector
Joseph SlatteryDirector
Thomas McLainExecutive Officer
Kapil DhingraDirector
Steven SoignetDirector
William KellyExecutive Officer
Geert-Jan MulderDirector
John BoyceExecutive Officer, Director

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Jul 3, 2017 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Exosome Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.